Foresite Capital Opportunity Management V, LLC, 10% Owner at Theseus Pharmaceuticals, Inc. (THRX), bought 250,000 shares at $5.00 ($1.3M) on 2022-12-29, disclosed to the SEC on 2023-01-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| THRX | BUY | 2023-07-19 | $4.2M | — | Filing → |
| PRDS | BUY | 2023-04-06 | $1.2M | — | Filing → |
| PRDS | BUY | 2021-12-23 | $3.3M | — | Filing → |